Cipla announces Q4 & FY17 results
Cipla reports Q4 net loss of Rs. 61.8 crores, whereas the revenue was up by 8 per cent
Author
Havas Group acquires Sorento
The addition serves to establish Havas Health & You with a cornerstone health-and-wellness agency in the growing Indian market…
Growth hormone deficiency market to grow steadily : GlobalData
The global growth hormone deficiency (GHD) space, which covers the seven major markets is set to rise to $2.08 billion by 2026
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
Ozone Ayurvedics launches herbal solution for dry eyes
Enriched with 11 organic herbal actives, ITIS Plus Care Eye Drops brings relief to tired and irritated eyes
DSP wins patent infringement case against Sinopharm
High Court of Delhi grants permanent injunction against the manufacture and sale of Sinopharm's amoxicillin active pharmaceutical…
DoP asks manufacturers to disseminate revised price information to retailers, distributors and…
Documentary evidence of communication may protect manufacturers from the claim of overcharging the medicine
India to unveil new drug policy: Officials
According to GN Singh, Drug Controller General (India) a set of new procedures to facilitate clinical trials are expected to be…
Natco Pharma gets green nod for Rs 480 cr expansion project
The proposal is to increase the production capacity of 66 APIs and API intermediates
Sun Pharma Science Foundation recognises Indian scientists and young research scholars
Science Award winners announced for exemplary contribution and research in pharma and medical science